Association between photoreceptor integrity and visual outcome in diabetic macular edema

PurposeTo investigate the correlation between foveal photoreceptor integrity and final visual acuity (VA) after treatment of eyes with diabetic macular edema (DME), and to determine the visual prognostic factors.MethodsWe retrospectively studied 61 eyes of 52 patients with DME who were treated successfully with intravitreal triamcinolone injection (IVTA). Using spectral domain optical coherence tomography (SD-OCT), the eyes were categorized into three groups at the final visit according to restoration of the photoreceptor inner and outer segment junction (IS/OS) and the external limiting membrane (ELM): (1) the A group, with a completely visible IS/OS and ELM, (2) the B group, with a disrupted IS/OS and intact ELM, and (3) the C group, with a disrupted or loss of the IS/OS and ELM. Disrupted IS/OS length (DIL), disrupted ELM length (DEL), and mean disrupted IS/OS and ELM length (DIEL) were measured at the initial and final visits. Foveal thickness (FT), macular center thickness (MCT), and outer nuclear layer (ONL) thickness were also measured at the initial and final visits. Multivariate analysis testing was performed over the measured SD OCT variables.ResultsFinal VA was closely associated with IS/OS integrity at the final visit; final VA (logMAR) in the A group (0.21 ± 0.14; 31 eyes) or B group (0.31 ± 0.21; 15 eyes) was significantly better than that in the C group (0.45 ± 0.33; 15 eyes) (p < 0.001). Shorter DIL, DEL, and DIEL at the final visit were associated with better final VA. Multivariate analysis showed that DIEL (r = 0.564) have the greatest correlation coefficient with final VA compared to DIL (r = 0.561) and DEL (r = 0.540). Better VA, preservation of the IS/OS and ELM at the initial visit were associated with intact photoreceptor integrity after resolution of DME. However, MCT, FT, and ONL thickness had no significant correlation with photoreceptor integrity.ConclusionIS/OS and ELM are useful hallmarks for use in evaluation of foveal photoreceptor layer integrity, and are closely associated with final VA in DME. Pretreatment VA and photoreceptor status can predict potential restoration of photoreceptor integrity and subsequent visual recovery in DME.

[1]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[2]  M. Maia,et al.  Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. , 2007, Ophthalmology.

[3]  Masayuki Hata,et al.  The significance of external limiting membrane status for visual acuity in age-related macular degeneration. , 2010, American journal of ophthalmology.

[4]  S. Kishi,et al.  CORRELATION BETWEEN VISUAL ACUITY AND FOVEAL MICROSTRUCTURAL CHANGES IN DIABETIC MACULAR EDEMA , 2010, Retina.

[5]  Glenn J Jaffe,et al.  Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. , 2010, Ophthalmology.

[6]  S. Wolf,et al.  Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. , 2011, Investigative ophthalmology & visual science.

[7]  Richard F Spaide,et al.  OPTICAL COHERENCE TOMOGRAPHY IN UNILATERAL RESOLVED CENTRAL SEROUS CHORIORETINOPATHY , 2005, Retina.

[8]  A. Kampik,et al.  RESOLUTION OF DIABETIC MACULAR EDEMA AFTER SURGICAL REMOVAL OF THE POSTERIOR HYALOID AND THE INNER LIMITING MEMBRANE , 2000, Retina.

[9]  N. Tachi,et al.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. , 1996, American journal of ophthalmology.

[10]  M. Mandai,et al.  Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration , 2009, Japanese Journal of Ophthalmology.

[11]  T. Yatagai,et al.  Three-dimensional imaging of macular holes with high-speed optical coherence tomography. , 2007, Ophthalmology.

[12]  W. Freeman,et al.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. , 2010, American journal of ophthalmology.

[13]  A. Tsujikawa,et al.  INTEGRITY OF FOVEAL PHOTORECEPTOR LAYER IN CENTRAL RETINAL VEIN OCCLUSION , 2008, Retina.

[14]  T. Avitabile,et al.  Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. , 2005, American journal of ophthalmology.

[15]  Ali Erginay,et al.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.

[16]  T. Yatagai,et al.  [Improved visualization of foveal pathologies using fourier-domain optical coherence tomography]. , 2007, Nippon Ganka Gakkai zasshi.

[17]  A C Bird,et al.  Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. , 1975, The British journal of ophthalmology.

[18]  A. Tsujikawa,et al.  Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  V. Greenstein,et al.  A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina , 2009, Documenta Ophthalmologica.

[20]  G. Bresnick.  Diabetic maculopathy. A critical review highlighting diffuse macular edema. , 1983, Ophthalmology.

[21]  松本 英孝.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy , 2010 .

[22]  M. Blumenkranz,et al.  Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. , 1992, Ophthalmology.

[23]  J. Jonas,et al.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema. , 2003, Archives of ophthalmology.

[24]  H. Flynn,et al.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. , 1996, American journal of ophthalmology.

[25]  A. Tsujikawa,et al.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion , 2007, British Journal of Ophthalmology.

[26]  Kazuaki Miyamoto,et al.  Three-dimensional imaging of cystoid macular edema in retinal vein occlusion. , 2008, Ophthalmology (Rochester, Minn.).

[27]  H. Schatz.  GRID PHOTOCOAGULATION FOR DIFFUSE MACULAR EDEMA , 1985, Retina.

[28]  P. Kaiser,et al.  Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. , 2001, American journal of ophthalmology.

[29]  Y. Tano,et al.  Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. , 2009, Ophthalmology.

[30]  J. Jonas,et al.  Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. , 2003, Archives of ophthalmology.

[31]  P. Kaiser,et al.  Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration , 2009, British Journal of Ophthalmology.

[32]  U. Schmidt-Erfurth,et al.  A systematic correlation between morphology and functional alterations in diabetic macular edema. , 2010, Investigative ophthalmology & visual science.

[33]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[34]  R. Olk.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. , 1986, Ophthalmology.

[35]  T J Flotte,et al.  Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. , 1999, Ophthalmology.

[36]  F. Gutman,et al.  The natural course of central retinal vein occlusion. , 1979, Ophthalmology.

[37]  Joan W. Miller,et al.  Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. , 2002, Investigative ophthalmology & visual science.

[38]  H. Sakaguchi,et al.  Foveal microstructure and visual acuity in surgically closed macular holes: spectral-domain optical coherence tomographic analysis. , 2010, Ophthalmology.

[39]  A. Tsujikawa,et al.  Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion , 2008, Clinical & experimental ophthalmology.

[40]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.

[41]  J. Klancnik,et al.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study , 2004, British Journal of Ophthalmology.

[42]  I. Park,et al.  The Clinical Course of the Idiopathic Epiretinal Membrane After Surgery , 2009, Korean journal of ophthalmology : KJO.

[43]  A. Erginay,et al.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. , 2004 .

[44]  S. Priglinger,et al.  INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA , 2006, Retina.

[45]  A. Tsujikawa,et al.  Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.